Skip to main content
SpringerLink
Log in

Effect of rat andβ-human interferons on hyperacute experimental allergic encephalomyelitis in rats

  • Immunosuppression and Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Human interferon-β (human IFN-β) and rat interferon (rat IFN) were evaluated on experimental allergic encephalomyelitis (EAE) in rats, a delayed cellular reaction resembling human multiple sclerosis (MS). Rat IFN was active by intravenous and intracerebroventricular routes. It decreased the severity of clinical symptoms of paralysis during the 22 days of the assay. Human IFN-β, on the contrary, had no effect when similarly tested in this rat model. Cyclophosphamide delayed the onset of paralysis, but levamisole enhanced the severity of the EAE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. W.E. Stewart, The Interferon System, Springer-Verlag, Wien, New York 1979.

    Google Scholar 

  2. Z.E. Dziewanowska andS. Pestka,The human interferons, Med. Res. Rev.2, 325–353 (1982).

    PubMed  Google Scholar 

  3. W. Zschiesche,The interferons, Drugs of Today17, 393–415 (1982).

    Google Scholar 

  4. W. Braun andH.B. Levy,Interferon preparations as modifiers of immune responses, Proc. Soc. exp. Biol. Med.141, 769–773 (1972).

    PubMed  Google Scholar 

  5. E. De Maeyer andJ. De Maeyer-Guignard,Immuno-modulating properties of interferons, Phil. Trans. R. Soc. Lond.B299, 77–90 (1982).

    Google Scholar 

  6. J.J. Hooks andB. Detrik-Hooks,Immunoregulatory actions of interferon, Molec. Aspects Med.5, 183–196 (1982).

    Article  Google Scholar 

  7. J.W. Hadden,Immunomodulators in the immunotherapy of cancer and other diseases, Trends Pharm. Sci.3, 191–194 (1982).

    Article  Google Scholar 

  8. H. Strander andS. Einhorn,Interferon in cancer, Am. J. Clin. Oncol.5, 297–301 (1982).

    PubMed  Google Scholar 

  9. E. De Maeyer andH. Schellekens, Ed.,The Biology of the Interferon System, Elsevier Science Publishers, Amsterdam 1983.

    Google Scholar 

  10. D. Ververken, H. Carton andA. Billiau,Intrathecal administration of interferon in MS patients? InHuman immunity in neurological diseases, Nato Advanced Study Institutes Series24, 625–627 (1975).

    Google Scholar 

  11. L. Jacobs, J. O'Malley, A. Freeman andR. Ekes,Intrathecal interferon reduces exacerbations of multiple sclerosis, Science214, 1026–1028 (1981).

    PubMed  Google Scholar 

  12. S.L. Abreu,Suppression of experimental allergic encephalomyelitis by interferon, Immunol. Com.11, 1–7 (1982).

    Google Scholar 

  13. S.L. Abreu, J. Tondreau, S. Levine andR. Sowinski,Inhibition of passive localized experimental allergic encephalomyelitis by interferon, Int. Archs Allergy appl. Immun.72, 30–33 (1983).

    Google Scholar 

  14. S. Levine, Relationship of experimental allergic encephalomyelitis to human disease. InImmunological Disorders of the Nervous System, vol. 49, pp. 33–46. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 1971.

  15. I.R. Mackay, R. Carnegie andA.S. Coates,Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis: a review, Clin. Exp. Immunol.15, 471–482 (1973).

    PubMed  Google Scholar 

  16. P.Y. Paterson,Multiple sclerosis: an immunologic reassessment, J. Chronic. Dis.26, 119–126 (1973).

    Article  PubMed  Google Scholar 

  17. P.Y. Paterson, Autoimmune neurologic disease: experimental animal septems and implications for multiple sclerosis. InAutoimmunity: Genetic. Immunologic, Virologic and Clinical Aspects, pp. 643–692 (Ed.N. Talal). Academic Press, New York 1977.

    Google Scholar 

  18. E. Slattery, H. Taira, R. Broeze andP. Lengyel,Mouse interferons: production by Ehrlich ascites tumour cells infected by Newcastle disease virus and its enhancement by theophylline, J. Gen. Virol.49, 91–96 (1980).

    PubMed  Google Scholar 

  19. E. Dussaix, A. Gregoire, C. Chany, D.C. Thang andM.N. Thang,Purification of highly radioactive mouse interferon produced by Ehrlich ascites tumour cells induced by Sendai virus, J. Gen. Virol.64, 285–290 (1983).

    PubMed  Google Scholar 

  20. E.A. Havell andJ. Vilček,Production of a hightitered interferon in cultures of human diploid cells, Antimicrob. Ag. Chemother.2, 476–484 (1972).

    Google Scholar 

  21. S. Levine andR. Sowinski,Suppression of the hyperacute form of experiment allergic encephalomyelitis by drugs, Archs int. Pharmacodyn. Thér.230, 309–318 (1977).

    Google Scholar 

  22. F. Hertz, M.M. Chevrier andF.V. De Feudis,Effects of various substances on two types of inflammatory reactions in animals, Gen. Pharmacol.14, 419–427 (1983).

    PubMed  Google Scholar 

  23. B.H. Waksman, Evidence favorising delayed sensitization as the mechanism underlying experimental allergic encephalomyelitis, InAllergic Encephalomyelitis, pp. 419–443 (EdsM.W. Kies andE.C. Alvord Jr.), Charles C. Thomas, Springfield, Ill. 1959.

    Google Scholar 

  24. P.Y. Paterson,Transfer of allergic encephalomyelitis in rats by means of lymph node cells, J. exp. Med.111, 119–136 (1960).

    PubMed  Google Scholar 

  25. D.J. Whitehouse, M.W. Whitehouse andC. Pearson,Passive transfer of adjuvant-induced arthritis and allergic encephalomyelitis in rats using thoracic duct lymphocytes, Nature, Lond.224, 1322 (1969).

    Google Scholar 

  26. R.H. Laatsch, M.W. Kies, S. Gordon andE.C. Alvord,The encephalitogenic activity of myelin isolated by centrifugation, J. exp. Med.115, 777–788 (1962).

    Article  Google Scholar 

  27. J.J.F. Oger andB.G.W. Arnason, Immunosuppression in multiple sclerosis. InThe Suppression of experimental Allergic Encephalitis, pp. 275–283 (Ed.A.N. Davison), Academic Press 1980.

  28. P.Y. Paterson andE.D. Day,Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis, Clin. Immunol. Rev.1, 581–697 (1981–1982).

    Google Scholar 

  29. M.E. Rosenthale andC. Nagra,Comparative effects of some immunosuppressive and anti-inflammatory drugs on allergic encephalomyelitis and adjuvant arthritis, Proc. Soc. exp. Biol. Med.125, 149–153 (1967).

    PubMed  Google Scholar 

  30. M.E. Rosenthale, L.J. Datko, J. Kassarich andF. Schneider,Chemotherapy of experimental allergic encephalomyelitis (EAE), Archs int. Pharmacodyn. Thér.179, 251–275 (1969).

    Google Scholar 

  31. P.Y. Paterson,Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats, J. Immun.106, 1473–1479 (1971).

    PubMed  Google Scholar 

  32. R.C. Gerber, M.W. Whitehouse andK. Orr,Effect of gold preparations on the development and passive transfer of experimental allergic encephalomyelitis in rats, Proc. Soc. exp. Biol. Med.140, 1379–1384 (1972).

    PubMed  Google Scholar 

  33. H. Megel, A. Raychaudhuri, S. Goldstein, C.R. Kingsolving, I. Shemano andJ.G. Michael,Tilorone: its selective effects on humoral and cell mediated immunity, Proc. Soc. exp. Biol. Med.145, 513–518 (1974).

    PubMed  Google Scholar 

  34. S. Levine andR. Sowinski,Synergistic suppression of the hyperacute form of experimental allergic encephalomyelitis by tilorone and cycloleucine, Proc. Soc. exp. Biol. Med.156, 457–460 (1977).

    PubMed  Google Scholar 

  35. S. Levine, R. Sowinski andS. Abreu,Suppression of experimental allergic encephalomyelitis by tilorone: cell transfer and interferon studies, Immunopharmacology6, 23–30 (1983).

    Article  PubMed  Google Scholar 

  36. S.L. Abreu,Pharmacokinetics of rat fibroblast interferon, J. Pharmac. exp. Ther.226, 197–200 (1983).

    Google Scholar 

  37. D. Gillespie andW.A. Carter,Species specificity of interferon, Tex. Rep. Biol. Med.41, 37–42 (1981–82).

    Google Scholar 

  38. S.L. Abreu, M.S. Canella andJ. Hanke,Induction and cross-species activity of rat fibroblast-derived interferon, Microbios.30, 181–190 (1981).

    PubMed  Google Scholar 

  39. G. Renoux andM. Renoux,Effet immunostimulant d'un imidothiazole dans l'immunisation des souris contre l'infection par Brucella abortus, C.r. Acad. Sci.272, 349–351.

  40. J.M. Andrieu,Le Lévamisole, stimulant du système immunitaire chez l'animal et chez l'Homme Path. Biol.25, 57–66 (1977).

    Google Scholar 

  41. A. Komarek andF.M. Dietrich,Chemical prevention of experimental allergic encephalomyelitis in rats: a quantitative evaluation of steroids and various non-steroid drugs, Archs int. Pharmacodyn. Thér193, 249–257 (1971).

    Google Scholar 

  42. J. Mertin, M. Kremer, S.C. Knight, J.R. Batchelor, A.M. Halliday, P. Rudge, M.J.R. Healey, A. Compston, E.J. Thompson, M. Denman andP.B. Medawar,Double-blind controlled trial of immunosuppressive in the treatment of multiple sclerosis: final report, Lancet8294, 351–353 (1982).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoires UPSA, 128, rue Danton, B.P. 325, 92506, Rueil Malmaison Cedex, France

    F. Hertz & R. Deghenghi

Authors
  1. F. Hertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Deghenghi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hertz, F., Deghenghi, R. Effect of rat andβ-human interferons on hyperacute experimental allergic encephalomyelitis in rats. Agents and Actions 16, 397–403 (1985). https://doi.org/10.1007/BF01982879

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01982879

Keywords

Search

Navigation